Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.

@article{Froestl2012CognitiveE,
  title={Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.},
  author={W. Froestl and A. Muhs and Andrea Pfeifer},
  journal={Journal of Alzheimer's disease : JAD},
  year={2012},
  volume={32 4},
  pages={
          793-887
        }
}
Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging. Cognition refers to a capacity for information processing, applying knowledge, and changing preferences. It involves memory, attention, executive functions, perception, language, and psychomotor functions. The term nootropics was coined in 1972 when memory enhancing properties of piracetam were observed… Expand
51 Citations
Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
  • 24
  • PDF
Neurotransmitters and Memory
  • 3
Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
  • 16
  • PDF
Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review
  • 28
  • Highly Influenced
Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
  • 1
A Novel Heterocyclic Compound CE-104 Enhances Spatial Working Memory in the Radial Arm Maze in Rats and Modulates the Dopaminergic System
  • 10
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 1,721 REFERENCES
Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
  • 24
  • PDF
Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.
  • 14
  • PDF
Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
  • 14
Mechanisms of action of cognitive enhancers on neuroreceptors.
  • 41
  • PDF
Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.
  • 182
Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs.
  • 91
  • PDF
Metabotropic glutamate receptors as therapeutic targets for cognitive disorders.
  • 38
Putative cognitive enhancers in preclinical models related to schizophrenia: The search for an elusive target
  • 33
  • PDF
...
1
2
3
4
5
...